Linagliptin and Meropenem drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Linagliptin (linagliptin) and Meropenem (meropenem). Common drug interactions include clostridium test positive among females and pneumonia among males.

The phase IV clinical study analyzes what interactions people have when they take Linagliptin and Meropenem. It is created by eHealthMe based on reports of 37 people who take the same drugs from the FDA, and is updated regularly.

What is Linagliptin?

Linagliptin has active ingredients of linagliptin. eHealthMe is studying from 8,112 Linagliptin users. Check the latest studies of Linagliptin.

What is Meropenem?

Meropenem has active ingredients of meropenem. eHealthMe is studying from 33,295 Meropenem users. Check the latest studies of Meropenem.

On Jul, 14, 2026

37 people who take Linagliptin and Meropenem together, and have interactions are studied.

Linagliptin and Meropenem drug interactions.

What are the common drug interactions of Linagliptin and Meropenem, by gender? *:

female:

Clostridium test positive
Pain in extremity
Abdominal pain upper
Bone density decreased
Decreased appetite
Haematemesis (vomiting of blood)
Headache (pain in head)
Osteoporosis (bones weak and more likely to break)
Pancreatitis acute (sudden inflammation of pancreas)
Tooth loss

male:

Pneumonia
Upper gastrointestinal haemorrhage (upper gastrointestinal bleeding)
Diverticulitis (digestive disease which involves the formation of pouches (diverticula) within the bowel wall)
Renal failure (kidney dysfunction)
Respiratory failure (inadequate gas exchange by the respiratory system)
Sepsis (a severe blood infection that can lead to organ failure and death)
Hyperglycaemia (high blood sugar)
Aspartate aminotransferase increased
Blood alkaline phosphatase increased
Bowel movement irregularity

What are the common drug interactions of Linagliptin and Meropenem, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

Duodenal ulcer haemorrhage (bleeding duodenal ulcer)
Malignant neoplasm of renal pelvis (cancer tumour of ureter)
Melaena (the passage of black, tarry stools)
Oesophageal varices haemorrhage (bleeding from extremely dilated sub-mucosal veins in the lower third of the oesophagus)
Pneumonia
Septic shock (shock due to blood infection)
Upper gastrointestinal haemorrhage (upper gastrointestinal bleeding)
Urinary tract infection
Acute hepatic failure
Hyperkalaemia (damage to or disease of the kidney)

60+:

Clostridium test positive
Pneumonia
Circulatory collapse
Diarrhoea
Febrile neutropenia (fever with reduced white blood cells)
Myelosuppression (a decrease in the production of blood cells)
Neutrophil count decreased (less than normal number of neutrophil a type of blood cell)
Skin disorder (skin disease)
Abdominal discomfort
Acute myeloid leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts)

What are the existing conditions these people have? *

Diabetes: 8 people, 21.62%
High Blood Pressure: 7 people, 18.92%
Urinary Tract Infection: 5 people, 13.51%
Constipation: 5 people, 13.51%
Hypotension (abnormally low blood pressure): 5 people, 13.51%
Fever: 4 people, 10.81%
Type 2 Diabetes: 4 people, 10.81%
Diarrhea: 4 people, 10.81%
Pain: 3 people, 8.11%
High Blood Cholesterol: 3 people, 8.11%

* Approximation only. Some reports may have incomplete information.

Do you take Linagliptin and Meropenem?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously